T2 Biosystems Inc EV/Sales
Quel est le EV/Sales de T2 Biosystems Inc?
Le EV/Sales de T2 Biosystems Inc est 10.64
Quelle est la définition de EV/Sales?
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
EV/Sales des entreprises dans Health Care secteur sur NASDAQ par rapport à T2 Biosystems Inc
Que fait T2 Biosystems Inc?
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
Entreprises avec ev/sales similaire à T2 Biosystems Inc
- Poly Ppty Dvlp Co Ltd a EV/Sales de 10.62
- Inventiva SA a EV/Sales de 10.62
- IM+ Capitals a EV/Sales de 10.63
- Telesites SAB de CV a EV/Sales de 10.63
- RioCan Real Estate Investment Trust a EV/Sales de 10.63
- Network-1 Technologies Inc a EV/Sales de 10.64
- T2 Biosystems Inc a EV/Sales de 10.64
- Lattice Semiconductor a EV/Sales de 10.65
- Cardax a EV/Sales de 10.66
- LXI REIT Plc a EV/Sales de 10.66
- Evotec SE a EV/Sales de 10.67
- Eve & Co a EV/Sales de 10.67
- FSA a EV/Sales de 10.68